Anúncio
Anúncio
RNXT
RenovoRx, Inc. Common Stock
1.12
USDPatrocinado
-0.03
-2.61%
09 de jan., 13:04 UTC -5
Abrir
Relatórios de Lucros RNXT
Rácio de surpresa positiva
RNXT separação 11 de 17 últimas estimativas.
65%
Próximo Relatório
Data do Próximo Relatório
30 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$456.28K
/-$0.08
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+71.53%
/--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+961.11%
/-38.46%
RenovoRx, Inc. Common Stock earnings per share and revenue
On 13 de nov. de 2025, RNXT reported earnings of -0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.08 USD, resulting in a 1.96% surprise. Revenue reached 266.00 mil, compared to an expected 413.44 mil, with a -35.66% difference. The market reacted with a -23.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of -0.08 USD, with revenue projected to reach 456.28 mil USD, implying an aumentar of 0.00% EPS, and aumentar of 71.53% in Revenue from the last quarter.
FAQ
What were RenovoRx, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, RenovoRx, Inc. Common Stock reported EPS of -$0.08, beating estimates by 1.96%, and revenue of $266.00K, -35.66% below expectations.
How did the market react to RenovoRx, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -23.03%, changed from $0.97 before the earnings release to $0.75 the day after.
When is RenovoRx, Inc. Common Stock expected to report next?
The next earning report is scheduled for 30 de mar. de 2026.
What are the forecasts for RenovoRx, Inc. Common Stock's next earnings report?
Based on 6
analistas, RenovoRx, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of $456.28K for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio